United States · FDA National Drug Code directory
fingolimod
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68462-166_6640fd85-57d1-4ec5-b555-8dce3037d409
- Product NDC
- 68462-166
- Form
- CAPSULE
- Composition / generic term
- fingolimod
- Labeler
- Glenmark Pharmaceuticals Inc., USA
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20220928
- Source listing expiry
- 20271231
Source-listed ingredients
- FINGOLIMOD HYDROCHLORIDE — .5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 7 BLISTER PACK in 1 CARTON (68462-166-07) / 7 CAPSULE in 1 BLISTER PACK · 68462-166-07
- 28 CARTON in 1 CARTON (68462-166-15) / 14 BLISTER PACK in 1 CARTON (68462-166-41) / 14 CAPSULE in 1 BLISTER PACK · 68462-166-15
- 30 CAPSULE in 1 BOTTLE (68462-166-30) · 68462-166-30
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →